# LIKMEZ
> **NDA216755** · New Drug Application · Sponsor: SAPTALIS PHARMS · Approved 2023-09-22
## Drug
- **FDA Application Number:** NDA216755
- **Application type:** New Drug Application
- **Brand name:** LIKMEZ
- **Generic name:** METRONIDAZOLE ORAL
- **Active ingredients:** METRONIDAZOLE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SAPTALIS PHARMS
- **Manufacturer:** Kesin Pharma Corporation
- **First approval:** 2023-09-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216755)
---
*AI Analytics · CC0 1.0*